Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-14-049424

Director acquired 578 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
REARDON WILLIAM S Director 2014-06-24 Option exercise +578 $19.75 $11,416 1,412 D
Derivatives
REARDON WILLIAM S Director 2014-06-24 Option exercise · Subscription Rights −1,134 0 D
Loading xslF345X03/a4.xml…